Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus

PHASE2CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

March 21, 2025

Study Completion Date

March 21, 2025

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

BMS-986165

Specified dose on specified days

Trial Locations (98)

0

Local Institution - 0108, Barranquilla

110

Local Institution - 0137, Taipei

1111

Local Institution - 0100, CABA

1430

Clinica Adventista Belgrano, Ciudad Autonoma de Buenos Aires

2000

Local Institution - 0098, Rosario

4032

Local Institution - 0039, Debrecen

5500

Local Institution - 0095, Mendoza

5700

Local Institution - 0038, Gyula

6725

Local Institution - 0045, Szeged

10002

Local Institution - 0051, Taipei

10016

Local Institution - 0131, New York

10630

Local Institution, Taipei

11201

Local Institution - 0123, Brooklyn

16499

Local Institution - 0053, Suwon

19610

Local Institution - 0035, Wyomissing

28204

Local Institution - 0031, Charlotte

29010

Local Institution - 0126, Málaga

29425

Local Institution - 0121, Charleston

30046

Local Institution - 0050, Lawrenceville

30303

Local Institution - 0094, Atlanta

32603

Local Institution - 0140, Gainesville

32835

Local Institution - 0133, Orlando

33180

Local Institution - 0115, Aventura

33511

Local Institution - 0044, Brandon

33613

Local Institution - 0048, Tampa

37000

Local Institution - 0080, León

37160

Local Institution - 0086, León

38305

Local Institution - 0001, Jackson

40201

Local Institution - 0052, Taichung

41014

Local Institution - 0124, Seville

45070

Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V., Zapopan

64000

Local Institution - 0084, Monterrey

73104

Local Institution - 0064, Oklahoma City

75150

Local Institution - 0046, Mesquite

75390

Local Institution - 0114, Dallas

77084

Local Institution - 0037, Houston

78213

Local Institution - 0082, San Luis Potosí City

78745

Tekton Research - Austin, Austin

90502

Local Institution - 0049, Torrance

92020

Local Institution - 0030, El Cajon

110221

Local Institution - 0101, Bogotá

150023

Local Institution - 0068, Yaroslavl

150030

Local Institution - 0060, Yaroslavl

191045

Local Institution - 0062, Saint Petersburg

197341

Local Institution - 0058, Saint Petersburg

214025

Local Institution - 0070, Smolensk

240277

Local Institution - 0002, Râmnicu Vâlcea

250001

Local Institution - 0103, Chía

250252

Local Institution - 0096, Zipaquirá

460018

Local Institution - 0057, Orenburg

500283

Local Institution - 0033, Brasov

600005

Local Institution - 0055, Vladimir

620043

Local Institution - 0061, Yekaterinburg

630099

Local Institution - 0072, Novosibirsk

650066

Local Institution - 0056, Kemerovo

800578

Local Institution - 0004, Galati

9808574

Local Institution - 0063, Sendai

35233-1913

Local Institution - 0077, Birmingham

06520

Local Institution - 0074, New Haven

32174-1139

Local Institution - 0032, Ormond Beach

27599-7280

Local Institution - 0071, Chapel Hill

78731-3146

Local Institution - 0041, Austin

C1046

Local Institution - 0125, Ciudad Autonoma de Buenos Aires

T4000AXL

Local Institution - 0091, San Miguel de Tucum

X5004FHP

Local Institution - 0122, Córdoba

40150-150

Local Institution - 0116, Salvador

74110-120

Local Institution - 0118, Goiߡ

36010-570

Local Institution - 0106, Juiz de Fora

80030-110

Local Institution - 0120, Curitiba

90480-000

Local Institution - 0107, Porto Alegre

09715-090

Local Institution - 0111, São Bernardo do Campo

01228-200

Local Institution - 0105, São Paulo

T2N 4Z6

University of Calgary, Calgary

M5T 2S8

Local Institution - 0136, Toronto

260-8712

National Hospital Organization Chibahigashi National Hospital, Chiba

807-8556

Local Institution - 0092, Kitakyushu

060-8604

Local Institution - 0119, Sapporo

060-8648

Hokkaido University Hospital, Sapporo

329-0498

Local Institution - 0069, Shimotsuke

104-8560

Local Institution - 0065, Chuo-ku

113-8431

Local Institution - 0078, Tokyo

162-8655

Local Institution - 0066, Tokyo

173-8610

Local Institution - 0093, Tokyo

06760

Local Institution - 0087, Mexico City

85-168

Local Institution - 0025, Bydgoszcz

64-000

Local Institution - 0015, Kościan

30-363

Local Institution - 0014, Krakow

31-011

Local Institution - 0027, Krakow

31-637

Local Institution - 0018, Krakow

20-607

Local Institution - 0016, Lublin

60-218

Local Institution - 0024, Poznan

41-200

Local Institution - 0029, Sosnowiec

02-172

Local Institution - 0019, Warsaw

02-665

Local Institution - 0022, Warsaw

50-363

Local Institution - 0010, Wroclaw

52-416

Local Institution - 0023, Wroclaw

110-744

Local Institution, Seoul

08208

Local Institution - 0138, Sabadell

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY